Krystal Biotech announced the first patient has been dosed in EMERALD-1, its phase 1/2 clinical trial evaluating KB801 for ...

When do your contact lenses expire? If you don't know the answer, you should hear what eye doctors have to say.

by epithelial cells in the front of the eye for the treatment of neurotrophic keratitis (NK), a rare, degenerative corneal disease that leads to corneal epithelial defects, ulcers, and perforation.

Trial evaluated number of supplemental injections needed for the treatment of DME for patients on ILUVIEN versus the ...

Monsoon eye infections are highly common due to humidity, stagnant water, and increased allergens, leading to conditions like ...

Eye drop administration of KB801 designed to enable sustained expression of NGF in the front of the eye Investor call and webcast to be held July 9 at 8:30 am ET to discuss program and trial design ...

Eye drop administration of KB801 designed to enable sustained expression of NGF in the front of the eye Investor call and webcast to be hel ...

EyeDura Therapeutics Inc. ( a developer of preservative-free sustained release ophthalmic therapies, announced that it ...

Krystal Biotech climbs after dosing begins in a phase I/II trial for KB801, a gene therapy eye drop targeting neurotrophic keratitis.

PITTSBURGH, July 09, 2025 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS) announced today that the first patient has been dosed in its Phase 1/2 clinical trial (“EMERALD-1”), ...

BRITS have been warned eyedrops used as a hayfever remedy have been recalled over risk of serious infection. Retailers have been advised to “stop supplying” the affected batch ...

TAIPEI (Taiwan News) — Taiwan’s Food and Drug Administration on Friday assured the public that an alternative vitamin A eye ...